Drug comparisons
Fremanezumab vs Zolmitriptan
Fremanezumab (Ajovy) is a CGRP monoclonal antibody for migraine prevention, while Zolmitriptan (Zomig) is a triptan for acute migraine treatment. Compare their mechanisms, side effects, and usage.
No comparison dimensions are available for this page.
Clinical context
Patients with frequent migraines often compare preventive options like Fremanezumab to acute treatments like Zolmitriptan to manage their condition effectively.
Bottom line
Both drugs are effective for migraine but target different aspects—Fremanezumab prevents attacks while Zolmitriptan treats them, making selection based on your specific migraine pattern.
All medication comparisons